On the other hand, when the CCN2 expression in oxaliplatin-resistant HCC cells was silenced using specific shRNA, the MAPK/Erk signaling and Id-1 expression were obviously inhibited (Fig. 5g). The gene discussed is ID1; the disease is hepatocellular carcinoma.